Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Assets (2016 - 2026)

Standard Biotools has reported Current Assets over the past 16 years, most recently at $454.3 million for Q4 2025.

  • Quarterly Current Assets rose 20.85% to $454.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $454.3 million through Dec 2025, up 20.85% year-over-year, with the annual reading at $454.3 million for FY2025, 20.85% up from the prior year.
  • Current Assets was $454.3 million for Q4 2025 at Standard Biotools, down from $472.4 million in the prior quarter.
  • Over five years, Current Assets peaked at $547.6 million in Q1 2024 and troughed at $72.1 million in Q4 2021.
  • The 5-year median for Current Assets is $218.9 million (2022), against an average of $271.1 million.
  • Year-over-year, Current Assets tumbled 40.11% in 2021 and then soared 220.79% in 2022.
  • A 5-year view of Current Assets shows it stood at $72.1 million in 2021, then soared by 189.76% to $208.8 million in 2022, then fell by 24.23% to $158.2 million in 2023, then skyrocketed by 137.58% to $375.9 million in 2024, then increased by 20.85% to $454.3 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Current Assets are $454.3 million (Q4 2025), $472.4 million (Q3 2025), and $506.0 million (Q2 2025).